Scientists are working to develop a vaccine against the deadly brain cancer and clinical trials for it are likely to begin early next year. Researchers have identified a gene mutation that results in glioma or brain cancer. A vaccine is now being developed to target this mutation. 'This frequent and highly specific mutation immediately aroused our attention as immunologists. In the cancer cells the exchange of amino acids lends the protein novel properties that can be recognised by the body's own immune cells' said Michael Platten of German Cancer Research Centre (DKFZ) Heidelberg Germany. An identical 'typo' in the DNA
